Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
Richard D. Kim and Debashis Sarker and Tim Meyer and Thomas Yau and Teresa Macarulla and Joong-Won Park and Su Pin Choo and Antoine Hollebecque and Max W. Sung and Ho-Yeong Lim and Vincenzo Mazzaferro and Joerg Trojan and Andrew X. Zhu and Jung-Hwan Yoon and Sunil Sharma and Zhong-Zhe Lin and Stephen L. Chan and Sandrine Faivre and Lynn G. Feun and Chia-Jui Yen and Jean-Francois Dufour and Daniel H. Palmer and Josep M. Llovet and Melissa Manoogian and Meera Tugnait and Nicolas Stransky and Margit Hagel and Nancy E. Kohl and Christoph Lengauer and Cori Ann Sherwin and Oleg Schmidt-Kittler and Klaus P. Hoeflich and Hongliang Shi and Beni B. Wolf and Yoon-Koo Kang,First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma,Cancer Discovery,2159-8274,American Association for Cancer Research (AACR),2019-12-01,9,12,1696-1707,https://cir.nii.ac.jp/crid/1364233268996970240,https://doi.org/10.1158/2159-8290.cd-19-0555